Alam Kamran, CFO of Taysha Gene Therapies ($TSHA), made four open market sales totaling $647,822 over the past year, with his latest on February 4, 2026. No purchases recorded. His sales rank 5,931st among 11,678 insiders, below the average of $8.6 million and 6.4 transactions.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 4, 2026 | Taysha Gene Therapies, Inc. | $TSHA | Alam Kamran | CHIEF FINANCIAL OFFICER | S | Common Stock | 1655 | $4.52 | 1,442,131.0000 | 353,309,524 | 0.11% | 0.00% |
| Jan. 26, 2026 | Taysha Gene Therapies, Inc. | $TSHA | Alam Kamran | CHIEF FINANCIAL OFFICER | S | Common Stock | 23849 | $4.61 | 1,443,786.0000 | 353,309,524 | 1.62% | 0.01% |
| Jan. 23, 2026 | Taysha Gene Therapies, Inc. | $TSHA | Alam Kamran | CHIEF FINANCIAL OFFICER | S | Common Stock | 78968 | $4.75 | 1,467,635.0000 | 353,309,524 | 5.11% | 0.02% |
| Jan. 12, 2026 | Taysha Gene Therapies, Inc. | $TSHA | Alam Kamran | CHIEF FINANCIAL OFFICER | A | Employee Stock Option (right to buy) | 231000 | $0.00 | 231,000.0000 | 353,309,524 | 9999.99% | 0.07% |
| Jan. 12, 2026 | Taysha Gene Therapies, Inc. | $TSHA | Alam Kamran | CHIEF FINANCIAL OFFICER | A | Common Stock | 359000 | $0.00 | 1,546,603.0000 | 353,309,524 | 30.23% | 0.10% |
| Aug. 21, 2025 | Taysha Gene Therapies, Inc. | $TSHA | Alam Kamran | CHIEF FINANCIAL OFFICER | S | Common Stock | 54491 | $2.85 | 1,187,603.0000 | 250,134,421 | 4.39% | 0.02% |
| May 31, 2023 | Taysha Gene Therapies, Inc. | $TSHA | Alam Kamran | CHIEF FINANCIAL OFFICER | A | Employee Stock Option (right to buy) | 12462 | $0.00 | 12,462.0000 | 0 | 9999.99% | 0.00% |
| March 11, 2025 | Taysha Gene Therapies, Inc. | $TSHA | Alam Kamran | CHIEF FINANCIAL OFFICER | F | Common Stock | 29843 | $1.69 | 1,242,094.0000 | 250,134,421 | 2.35% | 0.01% |
| Jan. 2, 2025 | Taysha Gene Therapies, Inc. | $TSHA | Alam Kamran | CHIEF FINANCIAL OFFICER | A | Employee Stock Option (right to buy) | 431000 | $0.00 | 431,000.0000 | 250,134,421 | 9999.99% | 0.17% |
| Jan. 2, 2025 | Taysha Gene Therapies, Inc. | $TSHA | Alam Kamran | CHIEF FINANCIAL OFFICER | A | Common Stock | 431000 | $0.00 | 1,271,937.0000 | 250,134,421 | 51.25% | 0.17% |
| Feb. 2, 2024 | Taysha Gene Therapies, Inc. | $TSHA | Alam Kamran | CHIEF FINANCIAL OFFICER | F | Common Stock | 1288 | $1.51 | 840,937.0000 | 116,121,482 | 0.15% | 0.00% |
| Jan. 2, 2024 | Taysha Gene Therapies, Inc. | $TSHA | Alam Kamran | Chief Financial Officer | A | Employee Stock Option (right to buy) | 590413 | $0.00 | 590,413.0000 | 116,121,482 | 9999.99% | 0.51% |
| Jan. 2, 2024 | Taysha Gene Therapies, Inc. | $TSHA | Alam Kamran | Chief Financial Officer | A | Common Stock | 590413 | $0.00 | 842,225.0000 | 116,121,482 | 234.47% | 0.51% |